ENTITY

Transcenta Holding (6628 HK)

Analysis

Health Care • China

Transcenta Holding Limited operates as a global biotherapeutics company. The Company develops therapeutic antibody molecules for oncology and selected non-oncology indications including bone and kidney disorders. Transcenta Holding provides services in China.

Refresh

Focused

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00